May 31st 2023
By Steve Rubin
Before every cancer scan, I used to prepare myself for the worst.
May 31st 2023
By Darlene Dobkowski, MA
Lynparza plus abiraterone was approved by the FDA for the treatment of patients with deleterious or suspected BRCA-mutated metastatic castration-resistant prostate cancer.
May 31st 2023
By Darlene Dobkowski, MA
The agency accepted a New Drug Application for repotrectinib, a TKI for the treatment of patients with locally advanced or metastatic non-small cell lung cancer.
May 31st 2023
By Doris Helene White
I lost my hair during cancer treatment, but now that it’s growing back, I no longer obviously look like a patient.
May 31st 2023
By Darlene Dobkowski, MA
Some symptoms of myeloproliferative neoplasms are “pretty broad,” highlighting the importance of open communication with cancer teams to manage the symptoms and improve quality of life.
May 31, 2023 11:00 PM
By Steve Rubin
May 31, 2023 5:00 PM
By Doris Helene White
May 30, 2023 5:00 PM
By Georgia Hurst
May 29, 2023 9:00 PM
By Brenda Denzler
May 12, 2023 7:00 PM
By Bryana Tanner
May 11, 2023 9:00 PM
By Robert Trebor
May 8, 2023 9:00 PM
By Denise Sirchie
May 4, 2023 1:00 PM
By Chester Freeman